Peginterferon alfa‐2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1

Saved in:
Bibliographic Details
Published inHepatology (Baltimore, Md.) Vol. 40; no. 3; pp. 760 - 761
Main Authors Pijak, Michal R., Gazdik, Frantisek, Hrusovsky, Stefan
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2004
Subjects
African Americans
Antiviral Agents - therapeutic use
Hepacivirus - classification
Hepatitis C, Chronic - drug therapy
Hepatitis C, Chronic - virology
Humans
Interferon-alpha - therapeutic use
Polyethylene Glycols - therapeutic use
Recombinant Proteins
Ribavirin - therapeutic use
RNA, Viral - analysis
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:0270-9139
1527-3350
DOI:10.1002/hep.20397